Warren Buffett Biogen Inc. Transaction History

Berkshire Hathaway Inc

  • $277 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$259.0 - $414.71 $167 Million - $267 Million
-643,022 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$268.85 - $341.04 $1.46 Million - $1.85 Million
-5,425 Reduced 0.84%
643,022 $203 Million
Q4 2019

Feb 14, 2020
BUY
$220.06 - $304.07 $143 Million - $197 Million
648,447 New
648,447 $192 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track Warren Buffett's Portfolio

Track Warren Buffett Portfolio

Follow Warren Buffett (Berkshire Hathaway Inc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Hathaway Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Hathaway Inc and Warren Buffett with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email